Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Environmental Pollution | journal | 1.827 Q1 | 301 | 945 | 1435 | 51441 | 8146 | 1398 | 5.36 | 54.43 | 40.65 |  |
| 52 | Therapeutic Advances in Vaccines | journal | 1.810 Q1 | 5 | 0 | 6 | 0 | 62 | 6 | 10.33 | 0.00 | 0.00 | |
| 53 | Critical Reviews in Toxicology | journal | 1.809 Q1 | 129 | 44 | 127 | 4733 | 717 | 118 | 5.51 | 107.57 | 43.64 | |
| 54 | Bioconjugate Chemistry | journal | 1.802 Q1 | 192 | 327 | 739 | 14596 | 3618 | 732 | 4.97 | 44.64 | 34.40 |  |
| 55 | PharmacoEconomics | journal | 1.797 Q1 | 118 | 112 | 311 | 4712 | 1002 | 258 | 3.45 | 42.07 | 38.50 | |
| 56 | Protein and Cell | journal | 1.790 Q1 | 94 | 99 | 320 | 3851 | 1173 | 280 | 4.01 | 38.90 | 40.62 | |
| 57 | Journal of NeuroImmune Pharmacology | journal | 1.774 Q1 | 91 | 66 | 229 | 3958 | 965 | 222 | 3.41 | 59.97 | 45.48 | |
| 58 | Human Genomics | journal | 1.770 Q1 | 68 | 37 | 76 | 1003 | 264 | 74 | 3.42 | 27.11 | 50.21 | |
| 59 | Expert Opinion on Therapeutic Targets | journal | 1.765 Q1 | 106 | 119 | 377 | 12656 | 1702 | 366 | 4.53 | 106.35 | 40.26 | |
| 60 | Archives of Toxicology | journal | 1.758 Q1 | 141 | 228 | 565 | 15263 | 2889 | 467 | 4.74 | 66.94 | 42.27 |  |
| 61 | Frontiers in Pharmacology | journal | 1.729 Q1 | 154 | 515 | 725 | 33384 | 3101 | 671 | 4.37 | 64.82 | 43.94 |  |
| 62 | Progress in Medicinal Chemistry | journal | 1.714 Q1 | 38 | 6 | 17 | 656 | 73 | 0 | 5.36 | 109.33 | 0.00 |  |
| 63 | Psychopharmacology | journal | 1.714 Q1 | 214 | 349 | 1217 | 21019 | 4440 | 1171 | 3.47 | 60.23 | 45.15 | |
| 64 | Handbook of Experimental Pharmacology | journal | 1.710 Q1 | 110 | 54 | 350 | 5252 | 1441 | 318 | 4.15 | 97.26 | 0.00 | |
| 65 | Forensic Toxicology | journal | 1.687 Q1 | 45 | 40 | 135 | 1429 | 510 | 120 | 3.91 | 35.73 | 41.92 |  |
| 66 | Nanomedicine: Nanotechnology, Biology, and Medicine | journal | 1.687 Q1 | 151 | 210 | 523 | 11807 | 3515 | 509 | 6.48 | 56.22 | 37.93 | |
| 67 | Toxicological Sciences | journal | 1.629 Q1 | 207 | 237 | 796 | 11380 | 3591 | 757 | 4.26 | 48.02 | 41.31 | |
| 68 | Clinical Trials | journal | 1.623 Q1 | 74 | 96 | 290 | 1871 | 527 | 238 | 1.92 | 19.49 | 45.92 | |
| 69 | Clinical Pharmacokinetics | journal | 1.599 Q1 | 184 | 110 | 269 | 6748 | 1381 | 244 | 4.68 | 61.35 | 41.99 | |
| 70 | Nanotoxicology | journal | 1.596 Q1 | 107 | 146 | 273 | 8051 | 1714 | 266 | 6.11 | 55.14 | 44.31 | |
| 71 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.586 Q1 | 64 | 45 | 168 | 2511 | 744 | 165 | 4.42 | 55.80 | 38.10 |  |
| 72 | CNS Neuroscience and Therapeutics | journal | 1.567 Q1 | 91 | 128 | 425 | 6031 | 1514 | 324 | 3.34 | 47.12 | 43.92 | |
| 73 | Alcoholism: Clinical and Experimental Research | journal | 1.565 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
| 74 | Pharmaceuticals | journal | 1.553 Q1 | 87 | 77 | 172 | 6189 | 897 | 165 | 4.62 | 80.38 | 48.70 | |
| 75 | Infection and Drug Resistance | journal | 1.551 Q1 | 65 | 33 | 101 | 1683 | 449 | 101 | 4.89 | 51.00 | 36.27 | |
| 76 | Addictive Behaviors | journal | 1.548 Q1 | 149 | 256 | 868 | 10607 | 2906 | 861 | 3.36 | 41.43 | 53.04 | |
| 77 | British Journal of Clinical Pharmacology | journal | 1.543 Q1 | 167 | 297 | 820 | 12341 | 3147 | 713 | 3.44 | 41.55 | 38.57 | |
| 78 | Molecular Pharmaceutics | journal | 1.538 Q1 | 156 | 404 | 1307 | 19053 | 6637 | 1293 | 4.93 | 47.16 | 37.29 | |
| 79 | Advances in Pharmacology | journal | 1.526 Q1 | 86 | 39 | 119 | 5476 | 463 | 0 | 3.76 | 140.41 | 0.00 | |
| 80 | Apoptosis : an international journal on programmed cell death | journal | 1.521 Q1 | 128 | 111 | 406 | 5963 | 1667 | 401 | 4.04 | 53.72 | 42.99 | |
| 81 | Journal of Studies on Alcohol and Drugs | journal | 1.498 Q1 | 137 | 132 | 341 | 4841 | 944 | 325 | 2.56 | 36.67 | 52.03 | |
| 82 | Toxicology and Applied Pharmacology | journal | 1.496 Q1 | 189 | 282 | 952 | 15536 | 4272 | 949 | 4.11 | 55.09 | 40.50 | |
| 83 | Topics in antiviral medicine | journal | 1.493 Q1 | 46 | 17 | 58 | 356 | 216 | 55 | 3.21 | 20.94 | 38.24 | |
| 84 | Expert Opinion on Drug Delivery | journal | 1.488 Q1 | 133 | 147 | 406 | 11820 | 2413 | 397 | 5.70 | 80.41 | 39.46 | |
| 85 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 141 | 416 | 11331 | 1366 | 386 | 3.31 | 80.36 | 41.82 | |
| 86 | Acta Pharmaceutica Sinica B | journal | 1.479 Q1 | 99 | 76 | 83 | 3746 | 450 | 74 | 5.42 | 49.29 | 44.67 |  |
| 87 | Toxicology | journal | 1.468 Q1 | 176 | 158 | 526 | 8293 | 2228 | 514 | 3.90 | 52.49 | 45.34 |  |
| 88 | Drug Metabolism and Disposition | journal | 1.466 Q1 | 194 | 217 | 713 | 9295 | 2946 | 706 | 4.26 | 42.83 | 38.88 | |
| 89 | Vaccines | journal | 1.457 Q1 | 85 | 48 | 95 | 4565 | 385 | 92 | 4.08 | 95.10 | 52.08 | |
| 90 | Drug Safety | journal | 1.454 Q1 | 140 | 105 | 313 | 5877 | 1117 | 270 | 3.47 | 55.97 | 40.10 | |
| 91 | Therapeutic Advances in Neurological Disorders | journal | 1.442 Q1 | 68 | 47 | 86 | 2043 | 394 | 82 | 4.87 | 43.47 | 36.40 | |
| 92 | ACS Medicinal Chemistry Letters | journal | 1.412 Q1 | 86 | 216 | 677 | 5223 | 2614 | 669 | 3.82 | 24.18 | 32.58 | |
| 93 | European Journal of Pharmaceutics and Biopharmaceutics | journal | 1.411 Q1 | 185 | 251 | 846 | 11318 | 4056 | 833 | 4.62 | 45.09 | 39.10 | |
| 94 | Journal of Cardiovascular Translational Research | journal | 1.395 Q1 | 60 | 54 | 241 | 2113 | 709 | 236 | 2.47 | 39.13 | 36.86 | |
| 95 | Current Neuropharmacology | journal | 1.385 Q1 | 103 | 120 | 169 | 12931 | 723 | 150 | 3.15 | 107.76 | 46.08 |  |
| 96 | Pharmacogenomics Journal | journal | 1.377 Q1 | 95 | 76 | 227 | 3861 | 966 | 227 | 3.87 | 50.80 | 40.13 | |
| 97 | Food and Chemical Toxicology | journal | 1.351 Q1 | 203 | 324 | 1576 | 18222 | 6729 | 1493 | 4.03 | 56.24 | 47.69 | |
| 98 | Journal of Biomolecular Screening | journal | 1.347 Q1 | 86 | 113 | 391 | 3588 | 1047 | 388 | 2.55 | 31.75 | 32.64 | |
| 99 | Prostaglandins and Other Lipid Mediators | journal | 1.341 Q1 | 86 | 46 | 148 | 2674 | 458 | 142 | 2.71 | 58.13 | 43.92 | |
| 100 | Investigational New Drugs | journal | 1.340 Q1 | 97 | 89 | 457 | 2942 | 1606 | 455 | 3.71 | 33.06 | 36.63 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data